2 news items
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
STRO
2 Apr 24
. "Sutro's research innovation represented in STRO-003 illustrates our leadership in ADC design. We look forward to collaborating with Ipsen's impressive
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
STRO
25 Mar 24
leadership team through the promotion of Jane Chung to President and Chief Operating Officer, a newly created role in which she will be responsible
- Prev
- 1
- Next